Brief: Celltrion Has Reviewed To Acquire Baxter International Inc's Biopharma Solution Unit, But No Decisions Have Been Made
21/03/2023 07:51
March 21 (Reuters) - Celltrion Inc 068270.KS :
* CELLTRION: HAS REVIEWED TO ACQUIRE BAXTER INTERNATIONAL
INC'S
BIOPHARMA SOLUTION UNIT, BUT NO DECISIONS HAVE BEEN MADE
Source text for Eikon: ID:
Further company coverage: 068270.KS
(Reporting by Hyunsu Yim)
((Hyunsu.Yim@thomsonreuters.com;))
Recent news on Celltrion
See all newsBrief: Celltrion Inc To Acquire 100 Billion Won Worth Of Own Shares
Brief: Celltrion Q1 Operating. Profit 322 Billion Won, Up 115% Y/Y
Brief: Celltrion To Cancel 100 Billion Won Treasury Shares
Brief: Celltrion Plans Phase 3 Clinical Trials For Keytruda Biosimilar With 220 Patients
Brief: Celltrion To Buy 100 Billion Won Of Own Shares